Pillstats
Rx only · Tablet, Film Coated · Oral

Glipizide And Metformin Hydrochloride

Glipizide + Metformin Hydrochloride

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6809
US makers6 labelers
Packages33
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.070$0.140$0.210$0.280Dec 2025Apr 2026Jul 2026
$0.242
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
6
Active US suppliers
73%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.0K6.0K9.1K12K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.0K
Rx · 2026 Q1
1.2M
Units dispensed
+4%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Lifesciences Limitedunknown12SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown12SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown3SUPPLYING
AvKAREunknown2SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING
REMEDYREPACK INC.repackager2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.